About Windtree Therapeutics, Inc. - Common Stock (WINT)
Windtree Therapeutics Inc is a biotechnology company focused on developing innovative therapies for respiratory and other serious medical conditions. The company's primary emphasis is on advancing treatments that target pulmonary diseases and disorders, utilizing their proprietary drug delivery systems and formulation technologies. Windtree works to address critical unmet needs in the healthcare space by leveraging its research and development capabilities to bring new therapeutic options to patients. Their pipeline includes candidates designed to enhance lung function and improve the quality of life for individuals suffering from respiratory conditions. Read More
Aditxt (NASDAQ: ADTX) has appointed Saundra Pelletier, CEO of Evofem Biosciences (OTCPK: EVFM), to its Board of Directors as the company advances toward commercialization and sharpens its focus on women’s health. Pelletier brings more than 30 years of global pharmaceutical experience, including launching and expanding brands across women’s reproductive health. At Evofem, she led the approval and commercial growth of Phexxi(R) and the acquisition of SOLOSEC(R), marking four straight years of net sales growth. She also holds board roles at Windtree Therapeutics (NASDAQ: WINT) and serves on nonprofit advisory boards focused on women’s empowerment and health.
Aditxt (NASDAQ: ADTX) has appointed Saundra Pelletier, CEO of Evofem Biosciences (OTCPK: EVFM), to its Board of Directors as the company advances toward commercialization and sharpens its focus on women’s health. Pelletier brings more than 30 years of global pharmaceutical experience, including launching and expanding brands across women’s reproductive health. At Evofem, she led the approval and commercial growth of Phexxi(R) and the acquisition of SOLOSEC(R), marking four straight years of net sales growth. She also holds board roles at Windtree Therapeutics (NASDAQ: WINT) and serves on nonprofit advisory boards focused on women’s empowerment and health.
Let's have a look at what is happening on the US markets after the closing bell on Tuesday. Below you can find the top gainers and losers in today's after hours session.
As the regular session of the US market concludes on Tuesday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.
The regular session of the US market on Wednesday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
U.S. stock futures were trading lower on Wednesday, after advancing for three consecutive sessions. Futures of major benchmark indices were lower in premarket trading.
Windtree Therapeutics shares are trading higher by 37% during Monday's session. The company regained compliance with Nasdaq's minimum bid price requirement, ensuring its continued listing.
Let's have a look at what is happening on the US markets after the closing bell on Friday. Below you can find the top gainers and losers in today's after hours session.
Wondering how the US markets performed one hour before the close of the markets on Friday? Discover the movers and shakers of today's session in our comprehensive analysis.
Wondering how the US markets performed in the middle of the day on Friday? Discover the movers and shakers of today's session in our comprehensive analysis.
Intrigued by the market activity in the middle of the day on Thursday? Uncover the key winners and losers of today's session in our insightful analysis.
